Company Profile: Merck & Co. Inc.


Company Profile: Merck & Co. Inc.

Merck & Co. is a global driven pharmaceutical company that manufactures and markets a very broad range of pharmaceutical products for both human and animal use. Their address is PO Box 100, Whitehouse Station, N.J. 08889. Their phone number is 908-423-1000 and their fax number is 908-735-1253. Their stock symbol is MRK and they are listed on the NYSE. The company URL is http://www.mrk.com. Last reported number of employees was 69,300.

Business summary:

Merck & Co., Inc. is a huge, international pharmaceutical company that discovers, develops, manufactures and markets a vast array of human and animal health products. It’s marketing efforts are direct and through its joint ventures. Merck provides pharmaceutical benefit services through Merck-Medco Managed Care, L.L.C. (Merck-Medco). The Company's operations are principally managed on a products and services basis and are comprised of two reportable segments, Merck Pharmaceutical (products marketed either directly or through joint ventures) and Merck-Medco. Merck Pharmaceutical products consist of therapeutic agents, sold by prescription, for the treatment of human disorders. Merck-Medco revenues are derived from the filling and management of prescriptions and health management programs.

Financial Summary:

Merck and Co., Inc. is an international pharmaceutical company that discovers, develops, produces and markets human/animal health products and services. Merck also provides pharmaceutical benefit services. For the three months ended 3/31/01, sales rose 28% to $11.35 billion. Net income rose 11% to $1.66 billion. These results reflected sales growth of prescription arthritis medicine and other newer and established products, partially offset by higher materials and production costs.

Officers of the company:

…Raymond Gilmartin, 60, Chairman, Pres, CEO …Judy Lewent, 52, CFO, Exec. VP …David Anstice, 52, Pres, The Americas & U.S. Human Health …Paul Bell, 55, Pres of Human Health-Asia Pacific …Richard Clark, 55, Pres, Merck-Medco Managed Care

Recent Events:

July 2 Dividend payment of $0.34 July 12 Price hit new 52-week low ($60.35)

Upcoming Events: None to report Company Statistics: The following company statistics are good as of the 22nd day of July, 2001. Note: Abbreviations are M=million, B=billion, ttm=twelve trailing months, mrq=most recent quarter, EBITDA= Earnings Before Interest Taxes Depreciation Amortization.

Price and Volume of Shares: …52-Week Low on 12-July-2001 of $60.35 …52-Week High on 30-Nov-2000 $96.688 …Daily Volume (3-month avg) 5.58M …Daily Volume (10-day avg) 7.96M

Stock Performance: MRK’s stock performance showed a 52-week change of +5.1%.

Share Related Information: MRK shows a market capitalization of $154.3B with 2.29B shares outstanding and a 2.27B share float.

Dividends and Splits: …annual dividend is $1.36 (indicated) …dividend yield is 2.02% …last split was a 2 for 1 on 17 May 1999 Stock per Share Data:

The copyright of the article Company Profile: Merck & Co. Inc. in Company Profiles is owned by George E. Banks Jr.. Permission to republish Company Profile: Merck & Co. Inc. in print or online must be granted by the author in writing.

Go To Page: 1 2

Articles in this Topic    Discussions in this Topic